Celik, A. et al. 2024. Capecitabine monotherapy as first-line treatment in advanced HER2-normal breast cancer – a nationwide, retrospective study. Acta Oncologica. 63, 1 (Jun. 2024), 494–502. DOI:https://doi.org/10.2340/1651-226X.2024.38886.